Proteomic profiling of bladder cancer for precision medicine in the clinical setting: A review for the busy urologist

At present, proteomic methods have successfully identified potential biomarkers of urological malignancies, such as prostate cancer (PC), bladder cancer (BC), and renal cell carcinoma (RCC), reflecting different numbers of key cellular processes, including extracellular environment modification, inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jayoung, Jin, Peng, Yang, Wei, Kim, Wun-Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606121/
https://www.ncbi.nlm.nih.gov/pubmed/33135400
http://dx.doi.org/10.4111/icu.20200317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606121/
https://www.ncbi.nlm.nih.gov/pubmed/33135400
http://dx.doi.org/10.4111/icu.20200317

Ejemplares similares